|
|
Volumn 40, Issue 9, 2009, Pages
|
|
Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
C REACTIVE PROTEIN;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
PYRROLE DERIVATIVE;
AGED;
BLOOD;
BLOOD PRESSURE;
BRACHIAL ARTERY;
BRAIN CIRCULATION;
CAROTID ARTERY;
CEREBROVASCULAR DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FACTUAL DATABASE;
FEMALE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STROKE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIUM;
VASODILATATION;
AGED;
BLOOD PRESSURE;
BRACHIAL ARTERY;
C-REACTIVE PROTEIN;
CAROTID ARTERIES;
CEREBROVASCULAR CIRCULATION;
CEREBROVASCULAR DISORDERS;
DATABASES, FACTUAL;
DOUBLE-BLIND METHOD;
ENDOTHELIUM, VASCULAR;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPIDS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
PYRROLES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
STROKE;
TREATMENT OUTCOME;
VASODILATION;
|
|
EID: 70349243757
PISSN: None
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.109.553941 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
